Search

everythinglearnresearchcommunity

for

Search:↓

Some cancer and immune system drugs can cause serious side effects, including heart, lung, nerve, and organ damage, which need careful monitoring and management.

Microspheres about 1.5 micrometers in size can best penetrate hair follicles, potentially reaching important stem cells.

The telogen phase of hair growth is active and important for preparing hair follicles for regeneration, not just a resting stage.

Potassium channel openers are effective in treating heart conditions, high blood pressure, pulmonary diseases, bladder issues, and hair loss, but more selective drugs are needed.

Stress hormone corticosterone blocks a growth factor to slow down hair stem cell activity and hair growth.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Some treatments for folliculitis decalvans work well, with tetracyclines and a mix of rifampicin and clindamycin being most effective.

Psoriasis can cause temporary or permanent hair loss.

Intralesional triamcinolone acetonide is effective for treating patchy hair loss, and dermoscopy helps detect treatment response and side effects early.

The document concludes that lifestyle changes and medical treatments can significantly reduce symptoms of Hidradenitis Suppurativa, a chronic skin condition.

Researchers created a mouse model of a type of rickets that does not cause hair loss.

KB2115 (eprotirome) can safely extend the hair growth phase without damaging cells or changing hair color.

Retinoids can prevent skin cancer in high-risk people but have side effects and require more research on dosing and effectiveness.

Alitretinoin may cause irreversible hair curling as a side effect.

Imiquimod used intravaginally for cervical issues can cause temporary hair loss, especially if severe side effects occur.

People with premature hair graying have an imbalance between harmful and protective molecules in their body, hinting that antioxidants might help.

Finasteride is effective for male hair loss, teledermatology is accurate and accepted, and cyclosporin helps treat toxic epidermal necrolysis.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

Chemotherapy can cause skin problems like hair loss, mouth sores, and skin darkening, and recognizing these can affect treatment decisions.

Human hair follicle organ culture is a useful model for hair research with potential for studying hair biology and testing treatments.

Estrogens help reduce skin aging, and SERMs might offer similar benefits without the risks of hormone therapy.

Liposomes could improve how skin care products work but are costly and not very stable.

Androgens play a role in female sexual function, and testosterone therapy can help women with low sexual desire, but more research is needed on treatments and long-term safety.

Light can turn on hair growth cells through a nerve path starting in the eyes.

Prolactin slows down hair growth in mice.

Facial dark spots can be caused by the sun, genetics, makeup, or medicine, and are diagnosed by patient history and skin tests.

IGF-1 increases whisker growth in transgenic mice.

A boy with chromosome 13q deletion syndrome developed eye cancer, a woman with breast cancer lost vision due to a rare side-effect of her treatment, a man's vision worsened after using a hair loss drug, and two rare disorders were discussed. Optical Coherence Tomography is useful for diagnosing and monitoring these conditions.

Eye exams are crucial for kids with 13q deletion syndrome, tamoxifen can cause vision loss, Propecia may lead to cataracts, Lipoid Proteinosis causes skin bumps, and OCT is useful for diagnosing macular diseases.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.